Clinical Trial Update: Safety of Purified Meningococcal Vaccine With Serogroups ACWY, in 3,000 Filipino Subjects Aged > 2 Years [Phase 4]

View source ↗

Summary

Phase 4 trial update assessing the safety of a serogroups ACWY meningococcal vaccine in about 3,000 Filipino subjects over age 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meningococcal Disease

Drugs mentioned

• Menveo (meningococcal group A, C, W-135 and Y conjugate vaccine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Infections, Meningococcal | Phase 4 | Status: COMPLETED | Results posted: 2017-03-14